Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
This study evaluated a six-day Gender-Based Violence (GBV) response training for PCL General Medicine (Health Assistant) students in Nepal. Students at Kantipur College of Medical Sciences (intervention group, n=40) received a facilitator-led training based on the WHO LIVES framework (Listen, Inquire, Validate, Enhance safety, Support) and Nepal's national Health Response to GBV package. Students at Lord Buddha College of Health Science (control group, n=40) received no training during the study period and were offered the same training after data collection. Both groups completed a questionnaire measuring GBV knowledge, attitudes, and self-efficacy before the training (baseline) and after the training (Day 6). The main comparison is the difference between groups in score change from baseline to Day 6. The study was retrospectively registered.
Full description
This pretest/posttest quasi-experimental study used a non-equivalent control group to evaluate a six-day GBV response training for first- and second-year PCL General Medicine (Health Assistant) students at two CTEVT-affiliated colleges in Kathmandu Valley, Nepal. The intervention group (Kantipur College of Medical Sciences, n=40) received a structured training based on the WHO LIVES framework and Nepal's national Health Response to GBV package, delivered through facilitated lectures, case-study discussions, role-play exercises, and reflective practice sessions. The control group (Lord Buddha College of Health Science, n=40) received no training before post-test data collection; for ethical reasons, the same training was offered to the control group afterwards (delayed-intervention design). Participants were stratified by academic year with proportional allocation.
A structured questionnaire administered through KoboToolbox measured three outcomes at baseline (T1) and Day 6 (T2): Knowledge (25 single-best-answer items, range 0-25), Attitudes (12 five-point Likert items, range 12-60, four reverse-scored), and Self-Efficacy (8 four-point Likert items, range 8-32). The three co-primary outcomes are between-group differences in gain scores (T2 - T1), analysed with Mann-Whitney U tests and Holm-Bonferroni correction across the three tests. Supporting analyses include Wilcoxon signed-rank tests, linear mixed-effects models (group × time), bias-corrected and accelerated (BCa) bootstrap effect sizes, MANCOVA adjusting for baseline, and sensitivity analyses (Welch t-test and permutation test).
The study was approved by the Institutional Review Committee of Madan Bhandari Academy of Health Sciences (IRC-169-083-084, 17 September 2026). Written informed consent was obtained from all participants [VERIFY: add "and from parents or guardians of participants under 18 years", if that is what happened]. The study was conducted in accordance with the Declaration of Helsinki and the ethical guidelines of the Nepal Health Research Council. The study was registered retrospectively.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
80 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal